University of Florida Grants Exclusive Worldwide License to Phageolytix for Breakthrough Phage Therapy Technology
The University of Florida has granted an exclusive worldwide license to Phageolytix, a biotechnology company specializing in innovative antimicrobial solutions, for multi-indication treatments with bacteriophage cocktails developed by UF researchers in the University of Florida's College of Medicine-Jacksonville.